N2OFF INC (NITO)

US80512Q4029 - Common Stock

0.1918  -0.02 (-10.92%)

After market: 0.195 +0 (+1.67%)

Fundamental Rating

2

Overall NITO gets a fundamental rating of 2 out of 10. We evaluated NITO against 83 industry peers in the Chemicals industry. While NITO has a great health rating, there are worries on its profitability. NITO is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

NITO had negative earnings in the past year.
NITO had a negative operating cash flow in the past year.
In the past 5 years NITO always reported negative net income.
In the past 5 years NITO always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -95.40%, NITO is doing worse than 96.39% of the companies in the same industry.
Looking at the Return On Equity, with a value of -102.09%, NITO is doing worse than 92.77% of the companies in the same industry.
Industry RankSector Rank
ROA -95.4%
ROE -102.09%
ROIC N/A
ROA(3y)-80.63%
ROA(5y)-154.16%
ROE(3y)-91.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 45.54%, NITO belongs to the best of the industry, outperforming 87.95% of the companies in the same industry.
NITO's Gross Margin has been stable in the last couple of years.
NITO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.46%
GM growth 5Y1.22%

7

2. Health

2.1 Basic Checks

NITO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NITO has been increased compared to 1 year ago.
The number of shares outstanding for NITO has been increased compared to 5 years ago.
There is no outstanding debt for NITO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

NITO has an Altman-Z score of -7.13. This is a bad value and indicates that NITO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of NITO (-7.13) is worse than 86.75% of its industry peers.
NITO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.13
ROIC/WACCN/A
WACC9.16%

2.3 Liquidity

A Current Ratio of 6.52 indicates that NITO has no problem at all paying its short term obligations.
NITO has a better Current ratio (6.52) than 96.39% of its industry peers.
A Quick Ratio of 6.42 indicates that NITO has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 6.42, NITO belongs to the top of the industry, outperforming 96.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.52
Quick Ratio 6.42

0

3. Growth

3.1 Past

NITO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.87%, which is quite impressive.
The Revenue for NITO has decreased by -53.87% in the past year. This is quite bad
The Revenue has been decreasing by -9.33% on average over the past years.
EPS 1Y (TTM)73.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.12%
Revenue 1Y (TTM)-53.87%
Revenue growth 3Y4.63%
Revenue growth 5Y-9.33%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

NITO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for NITO!.
Industry RankSector Rank
Dividend Yield N/A

N2OFF INC

NASDAQ:NITO (12/24/2024, 7:28:08 PM)

After market: 0.195 +0 (+1.67%)

0.1918

-0.02 (-10.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-12 2024-08-12
Earnings (Next)11-12 2024-11-12
Inst Owners1.01%
Inst Owner ChangeN/A
Ins Owners7.01%
Ins Owner Change0%
Market Cap2.11M
AnalystsN/A
Price TargetN/A
Short Float %1.07%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.03
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)-1.88
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0.02
BVpS0.49
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -95.4%
ROE -102.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.54%
FCFM N/A
ROA(3y)-80.63%
ROA(5y)-154.16%
ROE(3y)-91.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.46%
GM growth 5Y1.22%
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.52
Quick Ratio 6.42
Altman-Z -7.13
F-Score4
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.12%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-53.87%
Revenue growth 3Y4.63%
Revenue growth 5Y-9.33%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.06%
OCF growth 3YN/A
OCF growth 5YN/A